ArticleJournal of gynecologic oncology2022

Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study.

Tingyan Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.